Murine T cell reactivity with products of the minor lymphocyte stimulatory (Mls) locus correlates with the expression of particular variable (V) domains of the T cell receptor (TCR) B chain. It was recently demonstrated that Mls antigens are encoded by an open reading frame (ORF) in the 3' long terminal repeat of either endogenous or exogenous mouse mammary tumor virus (MMTV). Immature thymocytes expressing reactive TCR-Vo domains are clonally deleted upon exposure to endogenous Mtv's. Mature T cells proliferate vigorously in response to Mls-1 ~ (Mtv-7) in vivo, but induction of specific anergy and deletion after exposure to Mtv-7-expressing cells in the periphery has also been described. We show here that B cells and CD8 + (but not CD4 +) T cells from Mtv-7 + mice efficiently induce peripheral deletion of reactive T ceUs upon transfer to Mtv-7-recipients, whereas only B cells stimulate specific T cell proliferation in vivo. In contrast to endogenous Mtv-7, transfer of B, CD4 +, or CD8 + lymphocyte subsets from mice maternally infected with MMTV(SW), an infectious homologue of Mtv-7, results in specific T cell deletion in the absence of a detectable proliferative response. Finally, we show by secondary transfers of infected cells that exogenous MMTV(SW) is transmitted multidirectionally between lymphocyte subsets and ultimately to the mammary gland. Collectively our data demonstrate heterogeneity in the expression and/or presentation of endogenous and exogenous MMTV ORF by lymphocyte subsets and emphasize the low threshold required for induction of peripheral T cell deletion by these gene products.
Summary
Murine T cell reactivity with products of the minor lymphocyte stimulatory (Mls) locus correlates with the expression of particular variable (V) domains of the T cell receptor (TCR) B chain. It was recently demonstrated that Mls antigens are encoded by an open reading frame (ORF) in the 3' long terminal repeat of either endogenous or exogenous mouse mammary tumor virus (MMTV). Immature thymocytes expressing reactive TCR-Vo domains are clonally deleted upon exposure to endogenous Mtv's. Mature T cells proliferate vigorously in response to Mls-1 ~ (Mtv-7) in vivo, but induction of specific anergy and deletion after exposure to Mtv-7-expressing cells in the periphery has also been described. We show here that B cells and CD8 + (but not CD4 +) T cells from Mtv-7 + mice efficiently induce peripheral deletion of reactive T ceUs upon transfer to Mtv-7-recipients, whereas only B cells stimulate specific T cell proliferation in vivo. In contrast to endogenous Mtv-7, transfer of B, CD4 +, or CD8 + lymphocyte subsets from mice maternally infected with MMTV(SW), an infectious homologue of Mtv-7, results in specific T cell deletion in the absence of a detectable proliferative response. Finally, we show by secondary transfers of infected cells that exogenous MMTV(SW) is transmitted multidirectionally between lymphocyte subsets and ultimately to the mammary gland. Collectively our data demonstrate heterogeneity in the expression and/or presentation of endogenous and exogenous MMTV ORF by lymphocyte subsets and emphasize the low threshold required for induction of peripheral T cell deletion by these gene products.
T cell reactivity to antigens of the Mls locus correlates with expression of certain TCK-Ve domains (1) (2) (3) (4) (5) . The Mls loci have recently been shown to be encoded by open reading frames (ORF) 1 in the 3' long terminal repeat of different mouse mammary tumor viruses (MMTV) (6) (7) (8) . Expression of Mw-7, an endogenous proviral MMTV locus that determines the Mls-P phenotype (9) , leads to the intrathymic deletion of cells expressing TCR-V~6, 7; 8.1, or 9 (1) (2) (3) (4) (5) . Recently, we characterized an infectious equivalent of Mtv-7, called MMTV(SW) (10) , that exhibits the same TCR-V0 specificity. MMTV(SW) and MW-70RF molecules are almost identical in their carboxy termini, a polymorphic region that has been implicated in determining TCR-V0 specificity (11) . The availability of MMTV(SW) thus provides a unique opportunity to compare T cell responses to endogenous and exogenous MMTV ORF products.
In contrast to immature thymocytes, mature T cells respond by proliferation upon exposure to MMTV ORF products. In the case of Mtv-7, this initial response is followed paradoxically by functional inactivation (anergy) and even, in some cases, by donal deletion of the reactive T cells (12) (13) (14) (15) (16) (17) . Very little is known about the mechanisms leading to peripheral anergy and deletion of Mtv-7-reactive T cells, and it is still unclear whether these are causally related phenomena. Even less is known about exogenous MMTV, although there is evidence that lymphocytes may be involved in its transmission to the mammary gland (18) .
In an attempt to clarify some of these issues, we have injected highly purified lymphocyte subsets (B, CD8 +, or CD4 + cells) from mice carrying the endogenous Mtv-7 or the exogenous MMTV(SW), into normal recipients and monitored their ability to elicit clonal expansion or deletion of the reactive T ceils. Furthermore, we have used secondary transfer experiments to investigate the ability of these subsets to infect each other and ultimately lead to maternal transmission of the virus.
Materials and Methods
Mice. BALB/c, CBA/J, and CBA/Ca mice were obtained from Harlan Olac Ltd. (Bicester, UK) and BALB.D2.MIs-I' mice were maintained from breeding pairs originally provided by Dr. H. Festenstein (London Hospital Medical College, London, UK) (19) . Mice that were maternally infected with MMTV(SW) (BALB/c [SW]) were originally obtained from IFFA Credo (L'Arbresle, France) and subsequently maintained in our colony. For thymectomy, mice (5-6 wk of age) were anesthetised by intraperitoneal injection of 600 #1 of 0.04 M 2.2.2-tribromoethanol (1 g/ml in iso-amyl alcohol subsequently diluted 80x in PBS; Merck, Darmstadt, Germany). Thymectomy was performed by suction via a transcervicalretrosternal incision. Experiments were begun after the mice had rested for 7 d.
Antibodies. The following antibodies were used in this study: anti-V~6 (44.22.1) (20) , anti-V~8.2 (F23.2) (2), anti-V~14 (14.2) (21), anti-CD4 (GK1.5) (22) , anti-CD8 (53-6.7) (23), and antiThy-1 (AT83) (24) .
Cell Preparations. Suspensions of CD4 + and CD8 + T cells were prepared from lymph node, and B cells were from spleen. CD4 + or CD8 § T cells were first positively selected (to >95% purity) using directly coupled anti-CD4 or anti-CD8 microbeads and a magnetic cell separation device (MACS| Mihenyi Biotec GmbH, Bergisch-Gladbach, Germany) (25) . These cells were stained with fluorescently labeled (either FITC or PE) anti-CD4 or anti-CDS. B cells were enriched from spleen by anti-Thy-1 plus complement treatment and stained with a polyclonal rabbit F(ab)2 anti-mouse Ig FITC conjugate. These preparations were further purified to >99.5% homogeneity by sorting using a FACStar Plus | (Becton Dickinson & Co., Mountain View, CA). Peripheral blood was taken from the tail vein and mononuclear cells were isolated by centrifugation of heparinized samples (diluted with PBS-FCS) on a Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) cushion. (Table 1) . This response was only induced by B cells and not by purified (>99.5% pure) CD4 + or CD8 + T cells from Mtv-7 § mice. Since a previous report (15) showed that CD8 + T cells were also able to induce proliferation in mice of the H-2 k haplotype (after intravenous injection into thymectomized recipients), we injected either purified B cells or CD8 + T cells from CBA/J (Mtv-7 § , H-2 k) mice into the footpads of CBA/Ca (Mtv-7-, H-2 k) mice. Again, B cells efficiently stimulated a V~6 + CD4 + T cell response whereas CD8 + T cells did not ( Table 1 ). Similarly, we analyzed the response of BALB/c mice to purified B cells, CD8 + T cells, and CD4 + T cells from ~>6-moold BALB/c mice neonatally infected with MMTV(SW) (hereafter referred to as BALB/c [SW]). Infection of donor mice was verified by the absence of TCIK-V~6 + cells in the periphery before isolation of lymphocyte populations. In each case no proliferative response was detected ( Table 1) .
Results

Local
Deletion of Va6 + CO4 + T Cells Induced by Transfer of Lymphocyte Subsets from Mice Expressing Endogenous Mtv.7 or Infectious MMTV(SW).
In experiments conducted in parallel with the above stimulation studies, we monitored TCK-V~6 + CD4 + cells in the peripheral blood in recipient mice injected with the purified cell subsets. In all experiments, the specificity of deletion was verified by monitoring the levels of V~14 +CD4 + T cells. This control population remained largely unaffected in all experiments, except for slight, comPensatory increases in their percentage due to the deletion ofMtv-7-reactive T cells (data not shown). In agreement with a previous study (27) , specific deletion of V~6 § * T cells in BALB/c mice was detected as early as 2 wk after injection of either B cells or CD8 § T cells but not CD4 + T cells from BALB.D2 Mtv-7 + mice ( Fig. 1 A) . Dose-response and kinetic studies demonstrated that the deletion of TCK-V~6 + CD4 + cells induced by injection of CD8 + T cells was slightly faster and of greater magnitude than that induced by the same number of B cells (Fig. 1, B and C) . In all cases we observed continuous deletion over the entire time course (>160 d), suggesting persistence of Mtv-7 + cells in the recipients.
Since the mouse strains used for these experiments were Mls-1 ~ congenic, it seemed likely that permanent chimerism was established in the relevant subsets. This hypothesis was tested in experiments where B calls, CD8 + T ceils, and CD4 + T ceils were purified from mice that had previously received B cells or CD8 + T cells from BALB.D2 mice, and transferred into new host BALB/c mice. In these secondary transfers, ddetion was only induced by the CD8 + T cell subset and not by any other subset from mice that had received CD8 + T cells in the primary transfer (Fig. 2 A) . However, no subset (including B cells) from mice that had received BALB.D2 B cells originally was able to induce dele- tion upon retransfer (Fig. 2 B) , even though deletion of TCR-V~6+CD4 + cells in the donor animals was stable and as complete as in the recipients of CD8 + T cells. In contrast to the results obtained using cells from an Mtv-7 + donor, each lymphocyte subset (including CD4 + T cells) from ~>6-mo-old BALB/c(SW) mice induced Va-specific T cell deletion upon transfer to noninfected control mice (Fig. 3) . Consistent with this, we confirmed MMTV(SW) infection in each subset using a PCR assay to detect the presence of viral DNA as previously described (28, and data not shown). Deletion was induced more efficiently by transfer of T cell subsets than by B cells. Furthermore, in secondary transfers each of the subsets was able to induce a similar degree of deletion regardless of the original subset transferred (Fig. 4) . Thus, virus was transmitted from B cells to both CD4 + and CD8 + T cells, from CD8 + T cells to B cells and CD4 + T cells, and from CD4 + T cells to B cells and CD8 + T cells. It should be noted that the frequency of recipients in which deletion was observed after secondary transfer of the different subsets was higher for T cell recipients (greater for CD8 + than CD4 + T cells) than for B cell recipients, particularly if a lower cell number was injected in the secondary transfer (data not shown). 
Deletion of Reactive T Cells Occurs
Transfer of MMTV(SW)-infected Lymphocyte Subsets Leads to Mammary Gland Infection.
Since MMTV is maternally transmitted, recipient BALB/c mice, in which deletion of TCR-V~6+CD4 § cells was observed after second-round transfer of infected lymphocyte subsets (described above), were bred with normal BALB/c males. Offspring were bled at 4-5 wk of age and the levels of TCR-Va6 + CD4 + cells were followed to determine if milk transmission of MMTV(SW), and thus mammary gland infection, had occurred. In all the tested subset combinations of primary and secondary transfers, we observed ddetion of TCR-Va6 § § ceUs in pups demonstrating efficient infection of the mammary gland ( Table 2) .
Discussion
Previous work has suggested that superantigen-triggered deletion of mature T cells from the peripheral pool is associated with a prior expansion phase (15, 16, 29, 30) . However, we servations, significant cell cycling, as determined by measurement of DNA content, was only detectable among TCR-V~6+CD4 + cells when sufficient BALB.D2 B cells were injected (and not with either CD4 + or CD8 + T cells), whereas CD4 + T cells expressing TCR-V~14 + were not induced into cycle (our unpublished data). Thus, our data suggest that encounter of reactive T cells with the superantigen from either the endogenous proviral Mtv-7 or the exogenous equivalent MMTV(SW) will eventually lead to deletion of T cells bearing the appropriate V~ domains, irrespective of whether proliferation occurs. Furthermore, they demonstrate that peripheral T cell deletion is a more sensitive process than peripheral T cell stimulation, as for intrathymic deletion (31) (32) (33) , since it can occur in the absence of detectable expansion.
Our data indicate significant variation with respect to the ability of different cell types to present Mls-1 ~ in a form that is able to induce proliferation and/or deletion of the reactive V~6 + CD4 + T cells. An essential requirement for Mls-1 a presentation would, logically, be the expression ofMtv-70RF transcripts, which were detectable in all subsets using a PCRbased strategy (28, and our unpublished data). Clearly, constitutive expression of class II MHC is also required for the induction of proliferation of the ORF-reactive T cells since B cells but neither CD4 + nor CD8 + T cells (both generally accepted to be class II MHC negative in the mouse), were able to stimulate a classical Mls-1 ' response after transfer. However, the factors determining the capacity of a given cell type to present Mls-1 ~ for the induction of peripheral clonal deletion are much less clear. Consistent with a previous report (27) , both B cells and CD8 + T cells induced deletion, while similar doses of CD4 + T cells did not.
In considering this unexpected dichotomy between CD4 + and CD8 + T ceUs, it is conceivable that an MHC class IInegative cell expressing Mtv-7 can induce deletion by first transferring ORF products to an MHC class II-positive cell. Such transfers of molecules from CD8 + T cells have in fact been reported in other systems, i.e., for the lysosomal enzymes Cr and ~-glucuronidase (34, 35) . In the case of ORF products this may require transfer of only small amounts of the antigen since deletion is a more sensitive readout than proliferation (31) (32) (33) , which may explain the failure to detect transfer previously in one (36) but not in other reports (37, 38) . Alternatively, it is possible that the injected CD8 + T ceUs passively acquire class II MHC mob ecules (39) more efficiently than CD4 + cells, enabling them to directly present ORF product to reactive T cells. A final consideration for the putative transfer of ORF products is that it would probably require continuous exposure to ORF molecules, since B cells from a mouse that received CD8 + T cells (BALB.D2.Mls-1 a) did not stably acquire the Mtv-7 + phenotype and induce deletion upon retransfer. The greater deletion-inducing capacity of CD8 + T cells relative to B cells from Mls-l"-expressing mice raises the possibility that CD8 + T cells may proliferate or survive better than B cells after transfer to the host animal. This point is supported by the secondary subset transfers in which only CD8 + T cells were able to induce deletion of TCRVo6+CD4 + cells. Therefore, the inability of B cells to induce deletion after a second-round transfer may have been Each of the MMTV(SW)-infected subsets was able to act as a source of infectious virus that could be transmitted to the other lymphocyte subsets and ultimately to the mammary gland. This is consistent with a previous report showing T cell-dependent expression of viral gp52 by mammary gland after transfer of lymphoid ceils from MMTV(C3H)-infected mice (18) . Interestingly, virus transmission between subsets was slightly less efficient from B cell to B cell, judging by the lower frequency of second-round B cell recipients in which deletion occurred. Whether the efficiency of transmission from one subset to another varies due to different virus receptors * Primary subset donors were BALB/c (SW) mice. * Donors for the secondary subset transfers were the BALB/c recipients of the primary transfers. These mice were mated with normal (uninfected) BALB/c males. Offspring from these pairs were bled at 4-6 wk of age. The percentages of V~6 § and V~14 + T cells in the CD4 + T cell subset in peripheral blood were determined by flow cytometry. Data are given as mean _+ SD of four pups from each litter.
on different cell types, to the percentage of virus-infected cells in each subset at the time of transfer, or to the characteristics of the interactions between the subsets can not be determined using this approach. With respect to the latter, the lower efficiency of virus transfer from injected B cells to host B cells may reflect infrequent B-B interactions (as compared with T-B interactions) during which direct virus transfer could take place and/or the requirement for an intermediate virus host (e.g., T cells) for infection of B cells of the recipient animal. Additionally, the dependence of virus transfer on cellto-cell contact is consistent with the observation that viremia is generally not associated with infection by MMTV and that MMTV can not be transferred by plasma (41) . Indeed, using the most sensitive readout known for MMTV infection (i.e., T cell deletion) we have similarly failed to see any evidence for transmission of MMTV(SW) after transfer of plasma or cell-free culture supernatants from infected mice (our unpublished observations). These data argue against transfer of free MMTV particles in the cell injections described here. The kinetics of infection of the different lymphocyte subsets in maternally infected mice were not addressed in this study (all maternally infected animals were used as donors at i>6 mo of age). However, from the subset transfer experiments we know that detectable transmission of virus from one lyrephocyte subset to another can take place within at least 10 wk (earlier time points were not tested), but this may vary depending on the subset in question. The spread of the virus away from the site of infection (i.e., to the mammary gland and other peripheral lymphoid organs) via migration of infected cells must occur rapidly since deletion of peripheral TCR-V~6 + CD4 + cells can be detected as soon as 4 wk after birth or 2 wk after cell transfers. Furthermore, the breeding of second-round recipients indicated that virus transmission to the mammary gland could occur within 14 wk after transfer of the infected subsets, and probably more rapidly since maternally infected females of 8-9 wk of age can transmit virus to their first litter at this time (data not shown). We have recently obtained results demonstrating viral DNA in B cells but not T cells of draining lymph nodes in adult mice 6 d after virus injection, suggesting that these cells are the primary targets for viral infection (28) . The events that follow to bring about infection of other subsets are currently being assessed to determine the pathways taken by the virus to achieve mammary gland infection. The mode of infection of the mammary gland of the adult recipients, either directly by the transferred infected subset or via an intermediate cell type, and the requirement for superantigen-induced T cell responses in this transmission require further investigation.
